Skip to content
Rutgers.edu
New Brunswick
RBHS
Newark
Camden
Online
Rutgers Health

Facebook
Twitter

Search

Search for: Hit enter to search or ESC to close

Institute for Translational Medicine and Science

Home
About
Investigator Resources
Clinical Trials Resources
Education & Training
Faculty
News
Contact Us

Select Page

Home / News / Why are some viruses harmless and others deadly? A.J. te Velthuis is on the case. / AJteVelthuis_090221_0012_3000x1688_crop2_0

AJteVelthuis_090221_0012_3000x1688_crop2_0

by | Jan 27, 2022

Recent Posts

NJ ACTS Congratulates Chintan Dave
Register for the Road to Commercialization Seminar on April 13th!
Rutgers-Newark Report Looks at Troubling Educational Impact of School Segregation in New Jersey.
Supporting Nurses Under Pressure.
Unlocking a Cure for a Disease That Afflicts Millions.

Archives

2023
- March
- February
- January
2022
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
2021
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
2020
- December
- November
- October
- September
- August
- July
2019
- September
2018
- July
- April
2017
- October
- April
2016
- September
- August
- March
- January
2015
- July
- February
2013
- November

Categories

News (1,665)

THIS SITE

Investigator Resources

Clinical Trials Resources

Education & Training

CONTACT US

Rutgers Institute for Translational Medicine and Science
Rutgers, The State University of New Jersey
Child Health Institute of New Jersey Building
89 French Street, Suite 4210
New Brunswick, NJ 08901

Facebook
Twitter

© 2019-2020, Rutgers Institute for Translational Medicine and Science. All rights reserved.| Privacy Policy

Rutgers, The State University of New Jersey, is an equal access/equal opportunity institution. Individuals with disabilities are encouraged to direct suggestions, comments, or complaints concerning any accessibility issues with Rutgers web sites to accessibility@rutgers.edu or complete the Report Accessibility Barrier or Provide Feedback Form.